Contaminated, underdosed, or mislabeled products pose risks that have nothing to do with the inherent safety of the peptide
Common approaches include 4 weeks on followed by 2 weeks off, 6 weeks on followed by 4 weeks off, or running continuously until the injury resolves and then stopping
Not FDAapproved and not generally approved as a drug, supplement, or food in most countries
Sublingual B12 dosages can range from 1000 to 2500 mcg daily
Commonly reported side effects include: Injection Site Reactions: This is the most common side effect, where individuals may experience pain, redness, and swelling at the injection site
BPC-157 is expressly included in section S0 of WADAs 2026 Prohibited List and is prohibited at all times